12.28
Phreesia Inc stock is traded at $12.28, with a volume of 436.66K.
It is down -2.69% in the last 24 hours and up +14.34% over the past month.
Phreesia Inc is a provides an integrated software, payments, and engagement platform designed to address three foundational challenges in healthcare delivery: access to care, affordability of care, and patient health outcomes. Its platform is embedded directly into provider workflows and patient interactions, enabling healthcare organizations to activate patients, streamline administrative processes, and improve financial performance across the care continuum. The group serves a diverse group of healthcare organizations, including ambulatory practices, health systems, and hospitals, as well as life sciences companies, government entities, patient advocacy, public interest, and not-for-profit and other organizations.
See More
Previous Close:
$12.62
Open:
$12.69
24h Volume:
436.66K
Relative Volume:
0.38
Market Cap:
$759.05M
Revenue:
$495.59M
Net Income/Loss:
$9.18M
P/E Ratio:
82.47
EPS:
0.1489
Net Cash Flow:
$57.92M
1W Performance:
-1.84%
1M Performance:
+14.34%
6M Performance:
+2.76%
1Y Performance:
-56.16%
Phreesia Inc Stock (PHR) Company Profile
Name
Phreesia Inc
Sector
Industry
Phone
888-654-7473
Address
1521 CONCORD PIKE, WILMINGTON
Compare PHR vs VEEV, BTSG, TEM, HQY, TXG
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
PHR
Phreesia Inc
|
12.28 | 757.81M | 495.59M | 9.18M | 57.92M | 0.1489 |
|
VEEV
Veeva Systems Inc
|
243.75 | 39.23B | 3.32B | 941.65M | 1.64B | 5.6161 |
|
BTSG
Brightspring Health Services Inc
|
61.71 | 11.81B | 13.65B | 169.86M | 412.12M | 1.0758 |
|
TEM
Tempus Ai Inc
|
52.10 | 9.85B | 1.36B | -302.91M | -219.93M | -1.7182 |
|
HQY
Healthequity Inc
|
104.73 | 8.82B | 1.34B | 230.70M | 440.96M | 2.6695 |
|
TXG
10 X Genomics Inc
|
56.09 | 7.52B | 638.78M | -22.66M | 122.18M | -0.1744 |
Phreesia Inc Stock (PHR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-01-26 | Downgrade | Citizens | Mkt Outperform → Mkt Perform |
| Mar-31-26 | Downgrade | Citigroup | Buy → Neutral |
| Mar-31-26 | Downgrade | JP Morgan | Overweight → Neutral |
| Mar-31-26 | Reiterated | Needham | Buy |
| Mar-31-26 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Mar-31-26 | Downgrade | Truist | Buy → Hold |
| Jan-09-26 | Resumed | RBC Capital Mkts | Outperform |
| Jan-09-26 | Initiated | Wells Fargo | Overweight |
| Dec-09-25 | Initiated | Barclays | Overweight |
| Nov-13-25 | Initiated | BMO Capital Markets | Outperform |
| Sep-05-25 | Resumed | DA Davidson | Buy |
| Aug-27-25 | Initiated | Mizuho | Outperform |
| Jan-08-25 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Feb-26-24 | Initiated | Truist | Buy |
| Jan-17-24 | Upgrade | DA Davidson | Neutral → Buy |
| Jan-03-24 | Initiated | Barclays | Overweight |
| Apr-12-23 | Initiated | Stephens | Overweight |
| Jan-04-23 | Reiterated | Needham | Buy |
| Dec-13-22 | Upgrade | Citigroup | Neutral → Buy |
| Dec-09-22 | Upgrade | SVB Leerink | Mkt Perform → Outperform |
| Oct-13-22 | Initiated | DA Davidson | Neutral |
| Sep-16-22 | Initiated | KeyBanc Capital Markets | Overweight |
| Apr-14-22 | Initiated | Guggenheim | Buy |
| Jan-06-22 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| Dec-02-21 | Initiated | Jefferies | Buy |
| Sep-02-21 | Reiterated | Needham | Buy |
| Aug-27-21 | Initiated | Canaccord Genuity | Buy |
| Jul-13-21 | Initiated | JMP Securities | Mkt Outperform |
| Jun-08-21 | Initiated | Berenberg | Buy |
| Apr-29-21 | Resumed | JP Morgan | Overweight |
| Apr-01-21 | Initiated | Robert W. Baird | Outperform |
| Nov-11-20 | Initiated | Stephens | Overweight |
| Oct-27-20 | Initiated | Needham | Buy |
| Sep-22-20 | Initiated | DA Davidson | Buy |
| Jul-14-20 | Initiated | Citigroup | Neutral |
| May-15-20 | Initiated | Guggenheim | Buy |
| Apr-21-20 | Initiated | RBC Capital Mkts | Sector Perform |
| Apr-13-20 | Initiated | SVB Leerink | Outperform |
| Jan-31-20 | Initiated | KeyBanc Capital Markets | Overweight |
| Jan-09-20 | Initiated | Cantor Fitzgerald | Overweight |
| Dec-20-19 | Initiated | Raymond James | Outperform |
| Oct-11-19 | Initiated | Robert W. Baird | Outperform |
| Aug-13-19 | Initiated | JP Morgan | Overweight |
| Aug-12-19 | Initiated | Piper Jaffray | Overweight |
| Aug-12-19 | Initiated | Wells Fargo | Outperform |
| Aug-12-19 | Initiated | William Blair | Outperform |
| Jul-23-19 | Initiated | Chardan Capital Markets | Buy |
View All
Phreesia Inc Stock (PHR) Latest News
Phreesia, Inc. (NYSE:PHR) Given Consensus Rating of "Hold" by Brokerages - MarketBeat
Bronstein, Gewirtz & Grossman, LLC Encourages Phreesia, Inc. (PHR - The National Law Review
Phreesia, Inc. $PHR Stake Lessened by Dimensional Fund Advisors LP - MarketBeat
AQR Capital discloses 5.1% Phreesia (PHR) ownership in new Schedule 13G - Stock Titan
Bronstein, Gewirtz & Grossman, LLC Is Investigating Phreesia, Inc. (PHR) And Encourages Shareholders to Connect - ACCESS Newswire
PHR INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announce - The National Law Review
PHR INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Reminds - The National Law Review
Phreesia (NYSE:PHR) Shares Gap UpHere's Why - MarketBeat
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Aga - The National Law Review
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Phreesia, Inc. (PHR) and Encourages Shareholders to Learn More About the Investigation - ACCESS Newswire
Press Release: Phreesia Sets Release Date for Fiscal Second Quarter 2027 Results - 富途牛牛
Phreesia Sets Release Date for Fiscal Second Quarter 2027 Results - Business Wire
Phreesia Inc. (US71944F1066.SG) stock price, news, quote and history - Yahoo Finance Australia
Phreesia Inc (PHR) Earnings Forecast: Future EPS & Revenue Growth Estimates - tradingkey.com
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Phreesia, Inc. (PHR) and Encourages Investors to Learn More About the Investigation - ACCESS Newswire
PHREESIA, INC. (NYSE: PHR) SHAREHOLDER INVESTIGATION ALERT: - GlobeNewswire
PHR Stockholders Have Rights – If You Lost Money Investing in Phr - The National Law Review
Phreesia, Inc. (PHR) Stock Analysis: Exploring a 23% Upside Potential Amid Robust Revenue Growth - directorstalkinterviews.com
Investigation launched into Phreesia's leadersh... - pluang.com
Phreesia (PHR) director takes 685 deferred stock units over cash - Stock Titan
Phreesia, Inc. (NYSE: PHR) director takes fee as 377 deferred stock units - Stock Titan
Phreesia, Inc. (0A23.L) stock price, news, quote and history - Yahoo Finance UK
How Phreesia Inc. (PHR) Affects Rotational Strategy Timing - Stock Traders Daily
Phreesia (NYSE:PHR) Stock Price Down 8.4%Should You Sell? - MarketBeat
Phreesia Number of Employees 2026 | Employee Count & Headcount Data - Revelio Labs
Phreesia Inc (PHR) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Phreesia Inc (PHR) Balance Sheet - TradingKey
Phreesia Inc (PHR) Cash Flow - TradingKey
Phreesia Inc (PHR) Income Statement - TradingKey
PHR|Phreesia Inc|Price:11.265|Chg%:+0.535 - TradingKey
PHR|Phreesia Inc|Price:10.220|Chg%:+0.435 - TradingKey
Phreesia Inc (PHR) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Phreesia Inc (PHR) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Granahan Investment Management LLC Sells 1,412,006 Shares of Phreesia, Inc. $PHR - MarketBeat
Form DEF 14A Phreesia Inc For: 23 July - Investing.com UK
Form DEF 14A Phreesia Inc For: 23 July By Investing.com - Investing.com Canada
Phreesia partners with March of Dimes on maternal health By Investing.com - Investing.com Canada
Phreesia and March of Dimes Partner to Help Strengthen Physician-Patient Conversations and Improve the Health of Moms and Babies - Yahoo Finance
A Look at Phreesia Inc (PHR) After 5.6% Decline -- GF Value $27. - GuruFocus
Phreesia Launches AI Chatbot to Connect Patients With Healthcare Providers - Moomoo
Should Value Investors Buy Phreesia (PHR) Stock? - Yahoo Finance
MediFind Launches AI-Powered Chatbot to Help Patients Find and Book the Right Provider - Business Wire
Phreesia, Inc. (PHR) Stock Analysis: Strong Buy Ratings Signal A Promising 30.54% Upside - DirectorsTalk Interviews
Phreesia (PHR) Proxy filing Summary - Quartr
PHR SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Annou - The National Law Review
Phreesia (PHR) AGM 2026 Summary - Quartr
Phreesia’s Yvonne Hui sells $13,617 in company stock - Investing.com UK
Phreesia’s Yvonne Hui sells $13,617 in company stock By Investing.com - Investing.com Nigeria
Form 4 Phreesia Inc For: 17 July By Investing.com - Investing.com Nigeria
Phreesia Principal Accounting Officer Yvonne Hui disposes of 1,247 common shares worth $13,623.24 - Bitget
Phreesia (NYSE: PHR) officer sells 1,247 shares in 10b5-1 plan - Stock Titan
Phreesia Inc Stock (PHR) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):